<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title><![CDATA[MetaboloStasis Therapeutics ]]></title>
        <description><![CDATA[MetaboloStasis Therapeutics ]]></description>
        <link>https://thegrid.ai/metabolostasis/</link>
        <generator>The Grid</generator>
        <lastBuildDate>Sat, 19 Dec 2015 20:51:07 GMT</lastBuildDate>
        <atom:link href="https://thegrid.ai/metabolostasis/rss.xml" rel="self" type="application/rss+xml"/>
        <item>
            <title><![CDATA[Home ]]></title>
            <description><![CDATA[<article><h1>Home </h1><p>METABOLOSTASIS THERAPEUTICS is committed to the development of novel therapeutics for the treatment of rare diseases. Current research focuses on disorders of copper metabolism, an essential micro-nutrient whose deficiency or excess leads to immune dysfunction, heart disease, tumor development as well as dramatic neurodegeneration.</p><img src="https://s3-us-west-2.amazonaws.com/the-grid-img/p/8796183391d1517984cf93f5e6d9883cc177a872.jpg"></article>]]></description>
            <link>https://thegrid.ai/metabolostasis/home/index.html</link>
            <guid isPermaLink="false">f046ee45-12eb-4111-92f5-ee916d2ec222</guid>
            <pubDate>Sat, 19 Dec 2015 19:57:42 GMT</pubDate>
        </item>
    </channel>
</rss>